Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma

Carcinogenesis

Volumn 35, Issue 3, 2014, Pages 507-514

  Huang, Jin Lan ^a   Zheng, Lei ^a   Hu, Yan Wei ^a   Wang, Qian ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LONG UNTRANSLATED RNA; MICRORNA; MULTIDRUG RESISTANCE PROTEIN 1; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN P53; WNT PROTEIN;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; APOPTOSIS; BODY FLUID; CANCER CELL; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CELL FUNCTION; CELL INVASION; CELL PROLIFERATION; DNA METHYLATION; EPIGENETIC REPRESSION; EPIGENETICS; GENE EXPRESSION; GENE LOCUS; GENE SILENCING; GENE TARGETING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME; HUMAN; HUMAN CHROMOSOME; INTERACTIONS WITH RNA; LIFE CYCLE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; METASTASIS; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN RNA BINDING; RECURRENCE FREE SURVIVAL; REVIEW; RNA INTERFERENCE; RNA SPLICING; RNA STRUCTURE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; TUMOR INVASION; TUMOR MICROENVIRONMENT;

APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; DISEASE PROGRESSION; EPIGENESIS, GENETIC; HUMANS; LIVER NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; RNA SPLICING; RNA, LONG NONCODING;

EID: 84895788725     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt405     Document Type: Review

References (65)

1. Cervello,M. et al. (2012) Targeted therapy for hepatocellular carcinoma: novel agents on the horizon. Oncotarget, 3, 236-260.
2. El-Serag,H.B. et al. (2007) Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology, 132, 2557-2576.
3. Ponting,C.P. et al. (2009) Evolution and functions of long noncoding RNAs. Cell, 136, 629-641.
4. Wang,K.C. et al. (2011) Molecular mechanisms of long noncoding RNAs. Mol. Cell, 43, 904-914.
5. Wilusz,J.E. et al. (2009) Long noncoding RNAs: functional surprises from the RNA world. Genes Dev., 23, 1494-1504.
6. Qureshi,I.A. et al. (2010) Long non-coding RNAs in nervous system function and disease. Brain Res., 1338, 20-35.
7. Prensner,J.R. et al. (2011) The emergence of lncRNAs in cancer biology. Cancer Discov., 1, 391-407.
8. Xu,D. et al. (2013) Long noncoding RNAs associated with liver regeneration 1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/beta-catenin signaling. Hepatology, 58, 739-751.
9. Huang,J.F. et al. (2013) Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin. Hepatology, 57, 1882-1892.
10. Huang,X. et al. (2013) Characterization of human plasma-derived exosomal RNAs by deep sequencing. BMC Genomics, 14, 319.
11. Ren,S. et al. (2013) Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasmabased biomarker for diagnosing prostate cancer. Eur. J. Cancer, 49, 2949-2959.
12. Van Roosbroeck,K. et al. (2013) miRNAs and long noncoding RNAs as biomarkers in human diseases. Expert Rev. Mol. Diagn., 13, 183-204.
13. Guttman,M. et al. (2012) Modular regulatory principles of large non-coding RNAs. Nature, 482, 339-346.
14. Rinn,J.L. et al. (2012) Genome regulation by long noncoding RNAs. Annu. Rev. Biochem., 81, 145-166.
15. Yan,B. et al. (2012) Long noncoding RNA: its physiological and pathological roles. DNA Cell Biol., 31 (suppl. 1), S34-S41.
16. Clark,M.B. et al. (2012) Genome-wide analysis of long noncoding RNA stability. Genome Res., 22, 885-898.
17. Khalil,A.M. et al. (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc. Natl Acad. Sci. USA, 106, 11667-11672.
18. Niazi,F. et al. (2012) Computational analysis of functional long noncoding RNAs reveals lack of peptide-coding capacity and parallels with 3′ UTRs. RNA, 18, 825-843.
19. Novikova,I.V. et al. (2012) Sizing up long non-coding RNAs: do lncRNAs have secondary and tertiary structure? Bioarchitecture, 2, 189-199.
20. Halvorsen,M. et al. (2010) Disease-associated mutations that alter the RNA structural ensemble. PLoS Genet., 6, e1001074.
21. Volders,P.J. et al. (2013) LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res., 41, D246-D251.
22. Gupta,R.A. et al. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464, 1071-1076.
23. Novikova,I.V. et al. (2012) Structural architecture of the human long non-coding RNA, steroid receptor RNA activator. Nucleic Acids Res., 40, 5034-5051.
24. Wilusz,J.E. et al. (2008) 3′ end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell, 135, 919-932.
25. Li,C.H. et al. (2013) Targeting long non-coding RNAs in cancers: progress and prospects. Int. J. Biochem. Cell. Biol., 45, 1895-1910.
26. Wapinski,O. et al. (2011) Long noncoding RNAs and human disease. Trends Cell Biol., 21, 354-361.
27. Yang,F. et al. (2011) Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology, 54, 1679-1689.
28. Lin,R. et al. (2007) A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene, 26, 851-858.
29. Lai,M.C. et al. (2012) Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation. Med. Oncol., 29, 1810-1816.
30. Franco-Zorrilla,J.M. et al. (2007) Target mimicry provides a new mechanism for regulation of microRNA activity. Nat. Genet., 39, 1033-1037.
31. Panzitt,K. et al. (2007) Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology, 132, 330-342.
32. Wang,J. et al. (2010) CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res., 38, 5366-5383.
33. Yang,J.H. et al. (2013) ChIPBase: a database for decoding the transcriptional regulation of long non-coding RNA and microRNA genes from ChIP-Seq data. Nucleic Acids Res., 41, D177-D187.
34. Jeggari,A. et al. (2012) miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics, 28, 2062-2063.
35. Wang,K.C. et al. (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature, 472, 120-124.
36. Quagliata,L. et al. (2013) lncRNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients. Hepatology. doi:10.1002/hep.26740.
37. Hammerle,M. et al. (2013) Posttranscriptional destabilization of the liverspecific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1). Hepatology, 58, 1703-1712.
38. Cheetham,S.W. et al. (2013) Long noncoding RNAs and the genetics of cancer. Br. J. Cancer, 108, 2419-2425.
39. Zhu,Z. et al. (2012) An insertion/deletion polymorphism within RERTlncRNA modulates hepatocellular carcinoma risk. Cancer Res., 72, 6163-6172.
40. Liu,Y. et al. (2012) A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One, 7, e35145.
41. Gutschner,T. et al. (2012) The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol., 9, 703-719.
42. Pan,Y.F. et al. (2013) Expression profile of altered long non-coding RNAs in patients with HBV-associated hepatocellular carcinoma. J. Huazhong Univ. Sci. Technolog. Med. Sci., 33, 96-101.
43. Geng,Y.J. et al. (2011) Large intervening non-coding RNA HOTAIR is associated with hepatocellular carcinoma progression. J. Int. Med. Res., 39, 2119-2128.
44. Orozco,A.F. et al. (2010) Flow cytometric analysis of circulating microparticles in plasma. Cytometry A, 77, 502-514.
45. Xie,H. et al. (2013) Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed. Res. Int., 2013, 136106.
46. Lempiäinen,H. et al. (2013) Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion. Toxicol. Sci., 131, 375-386.
47. Yuan,S.X. et al. (2012) Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy. Hepatology, 56, 2231-2241.
48. Tsang,W.P. et al. (2007) Riboregulator H19 induction of MDR1-associated drug resistance in human hepatocellular carcinoma cells. Oncogene, 26, 4877-4881.
49. Du,Y. et al. (2012) Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18. J. Biol. Chem., 287, 26302-26311.
50. Yang,Z. et al. (2011) Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann. Surg. Oncol., 18, 1243-1250.
51. Eissmann,M. et al. (2012) Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol., 9, 1076-1087.
52. Hengartner,M.O. (2000) The biochemistry of apoptosis. Nature, 407, 770-776.
53. Zhou,Y. et al. (2012) MEG3 noncoding RNA: a tumor suppressor. J. Mol. Endocrinol., 48, R45-R53.
54. Yang,H. et al. (2013) Induction of the liver cancer-down-regulated long noncoding RNA uc002mbe.2 mediates trichostatin-induced apoptosis of liver cancer cells. Biochem. Pharmacol., 85, 1761-1769.
55. Yang,F. et al. (2013) Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol. Cell., 49, 1083-1096.
56. Lee,G.L. et al. (2011) Prostate cancer: diagnostic performance of the PCA3 urine test. Nat. Rev. Urol., 8, 123-124.
57. Zhang,L. et al. (2013) Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis, 34, 577-586.
58. Hanahan,D. et al. (2011) Hallmarks of cancer: the next generation. Cell, 144, 646-674.
59. Park,B.J. et al. (2005) The haploinsufficient tumor suppressor p18 upregulates p53 via interactions with ATM/ATR. Cell, 120, 209-221.
60. Tripathi,V. et al. (2013) Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet., 9, e1003368.
61. Braconi,C. et al. (2011) microRNA-29 can regulate expression of the long non-coding RNA gene MEG3 in hepatocellular cancer. Oncogene, 30, 4750-4756.
62. Zhou,Y. et al. (2007) Activation of p53 by MEG3 non-coding RNA. J. Biol. Chem., 282, 24731-24742.
63. Smits,G. et al. (2008) Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians. Nat. Genet., 40, 971-976.
64. Tsang,W.P. et al. (2010) Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Carcinogenesis, 31, 350-358.
65. Davis,M.E. et al. (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature, 464, 1067-1070.